img description

MARCH 2015
MorEx moves to intent-­‐to-­‐cure stage of MTL-­‐005 radiation enhancer head & neck cancer Phase 1 trial
March 2015: Find out more

MAY 2014
MorEx is attending BioTrinity in London, May 12th – 14th 2014: 
Please contact us if you would like to learn more about the MTL-005 programme at BioTrinity

MARCH 2014
MorEx present poster on pre-clinical safety data at the Society of Toxicology Annual Meeting,
March 2014: Find out more

MorEx present poster on pre-clinical efficacy data at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by ASCO / ASTRO, February 20-22, 2014: Find out more

Start of MTL-005 Phase 1 trial: Find out more

Formation of MorEx Development Partners LLP: Press release